Claudia Lanvers‐Kaminsky
University Hospital Münster(DE)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Adolescent and Pediatric Healthcare, Neuroblastoma Research and Treatments, Cancer therapeutics and mechanisms
Most-Cited Works
- → Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions(2010)436 cited
- → Drug‐induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies(2016)285 cited
- → A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia(2014)219 cited
- → Inhibitors of histone deacetylases as potential therapeutic tools for high‐risk embryonal tumors of the nervous system of childhood(2007)110 cited
- → Microarray analysis of Ewing’s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy(2008)96 cited
- → A comparison of genotyping arrays(2021)86 cited
- → Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity(2015)75 cited
- → Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials(2011)62 cited
- → Asparaginase pharmacology: challenges still to be faced(2017)62 cited
- Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin.(2003)